NASDAQ : ADGM
Adagio Medical Holdings, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 0.083 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.84M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.84M |
| Enterprise Value | 20.10M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 22.21M |
| Shares Outstanding | 22.21M |
| Shares Change (YoY) | +42.93% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.26% |
| Owned by Institutions (%) | 7.84% |
| Float | 8.43M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 3.55 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.41 |
| Quick Ratio | 1.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.38 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -657.76% |
| Return on Assets (ROA) | -35.52% |
| Return on Invested Capital (ROIC) | -47.62% |
| Return on Capital Employed (ROCE) | -75.31% |
| Weighted Average Cost of Capital (WACC) | 9.10% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$661,854 |
| Employee Count | 41 |
| Asset Turnover | n/a |
| Inventory Turnover | 0.05 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.07 |
| 52-Week Price Change | -93.03% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 0.75 |
| Relative Strength Index (RSI) | 25.87 |
| Average Volume (20 Days) | 2,320,683 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 132,959 |
| Short Previous Month | 1.29M |
| Short % of Shares Out | 0.60% |
| Short % of Float | 1.58% |
| Short Ratio (days to cover) | 0.03 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | -89,000 |
| Operating Income | -19.82M |
| Pretax Income | -27.14M |
| Net Income | -27.14M |
| EBITDA | -18.98M |
| EBIT | -19.82M |
| Earnings Per Share (EPS) | -$1.36 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 7.74M |
| Total Debt | 26.00M |
| Net Cash | -18.26M |
| Net Cash Per Share | -$0.82 |
| Equity (Book Value) | -415,000 |
| Book Value Per Share | -0.02 |
| Working Capital | 3.13M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -16.53M |
| Capital Expenditures | -37,000 |
| Depreciation & Amortization | 839,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -16.57M |
| FCF Per Share | -$0.75 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -42.93% |
| Shareholder Yield | -42.93% |
| Earnings Yield | -1,635.26% |
| FCF Yield | -898.85% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $3.33 |
| Price Target Difference | 3,915.66% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |